Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

826 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review.
Patel R, Evitt L, Mariolis I, Di Giambenedetto S, d'Arminio Monforte A, Casado J, Cabello Úbeda A, Hocqueloux L, Allavena C, Barber T, Jha D, Kumar R, Kamath RD, Vincent T, van Wyk J, Koteff J. Patel R, et al. Among authors: barber t. Infect Dis Ther. 2021 Dec;10(4):2051-2070. doi: 10.1007/s40121-021-00522-7. Epub 2021 Aug 24. Infect Dis Ther. 2021. PMID: 34426899 Free PMC article. Review.
Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy-Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review.
Llibre JM, Cahn PE, Lo J, Barber TJ, Mussini C, van Welzen BJ, Hernandez B, Donovan C, Kisare M, Sithamparanathan M, van Wyk J. Llibre JM, et al. Open Forum Infect Dis. 2022 Feb 10;9(4):ofac068. doi: 10.1093/ofid/ofac068. eCollection 2022 Apr. Open Forum Infect Dis. 2022. PMID: 35265729 Free PMC article.
A need for implementation science to optimise the use of evidence-based interventions in HIV care: A systematic literature review.
Cox J, Gutner C, Kronfli N, Lawson A, Robbins M, Nientker L, Ostawal A, Barber T, Croce D, Hardy D, Jessen H, Katlama C, Mallolas J, Rizzardini G, Alcorn K, Wohlfeiler M, Le Fevre E. Cox J, et al. Among authors: barber t. PLoS One. 2019 Aug 19;14(8):e0220060. doi: 10.1371/journal.pone.0220060. eCollection 2019. PLoS One. 2019. PMID: 31425524 Free PMC article.
Frailty in people living with HIV: an update.
Jones HT, Levett T, Barber TJ. Jones HT, et al. Among authors: barber tj. Curr Opin Infect Dis. 2022 Feb 1;35(1):21-30. doi: 10.1097/QCO.0000000000000798. Curr Opin Infect Dis. 2022. PMID: 34799510 Review.
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.
Strategies for Management of Antiretroviral Therapy (SMART) Study Group; Lundgren JD, Babiker A, El-Sadr W, Emery S, Grund B, Neaton JD, Neuhaus J, Phillips AN. Strategies for Management of Antiretroviral Therapy (SMART) Study Group, et al. J Infect Dis. 2008 Apr 15;197(8):1145-55. doi: 10.1086/529523. J Infect Dis. 2008. PMID: 18476293 Clinical Trial.
Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.
Rodger AJ, Fox Z, Lundgren JD, Kuller LH, Boesecke C, Gey D, Skoutelis A, Goetz MB, Phillips AN; INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group. Rodger AJ, et al. J Infect Dis. 2009 Sep 15;200(6):973-83. doi: 10.1086/605447. J Infect Dis. 2009. PMID: 19678756 Free PMC article. Clinical Trial.
Glasgow HIV conference on HIV Drug Therapy 2020.
Barber TJ, Waters LJ. Barber TJ, et al. J Virus Erad. 2021 Feb 13;7(1):100031. doi: 10.1016/j.jve.2021.100031. eCollection 2021 Mar. J Virus Erad. 2021. PMID: 33659068 Free PMC article. No abstract available.
826 results